Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.47 USD | -0.14% |
|
-2.11% | +32.95% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.73% | 2.8B | |
+17.73% | 125B | |
+13.55% | 108B | |
-6.56% | 24.21B | |
+0.47% | 22.78B | |
-11.25% | 17.96B | |
-41.74% | 16.43B | |
-13.83% | 16.37B | |
+1.59% | 13.58B | |
+27.42% | 11.66B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Sector Update: Health Care